| Reduced Risk Status: |
|
| IPM Compatibility: |
Per Requestor: Very Good Fit; Omega can be used in a rotation program, different FRAC code and mode of action that the ones already registered In vitro EC50=0.03 (µl/ml) against Neoscytalidium dimidiatum:06/23 ; VERY GOOD FIT: SEE REQUESTER'S COMMENT.: SOR
|
| Reasons for need: |
"Stem and Fruit Canker Disease" caused by the fungal pathogen Neoscytalidium dimidiatum; There are only two other fungicide compounds registered: Azoxystrobin (group 11) and Cyprodinil + Fludioxonil(groups 9 and 12). No enough to cover the 36 weeks in the season (start flowering March to last harvest in November). 18 weeks can be protected with conventional pesticides if these are applied in 14-day intervals, which leaves several critical weeks ~4-5 months without protection. We need more chemicals that can be added to the rotation:06/23
|
| Requesting State(s): |
FL:Gazis, R* ; TX:Laughlin, D ;
|
| PCR Use Pattern: |
Rate: 20 fl. oz/A ; Foliar/spray application; 2-4 applications per year; 14 days re-treatment interval. ISK recommends 4 applications of 13.8 fl. oz/A at 14-day intervals:10/24/sb
|
| EPA Default Residue Trials: |
13-4
|
| IR-4 Residue Trial Plan: |
ANY4
|
| Residue Protocol Use Pattern: |
|
| Efficacy/Crop Safety (E/CS) Data Required: |
|
| E/CS Research Comments: |
Gazis confirmed that E/CS data reflects 4 applications of 13.8 fl. oz/A at 14-day intervals:10/24sb
|
| Label Use Pattern Submitted To EPA: |
|
| EPA PIF Status: |
EPA GREEN: 08/23
|
| EPA Status: |
|
| EPA PRIA Date: |
|
| MRID: |
|
| Comments: |
ISK supports request as Potential: E/CS Data Before approval for Residue:07/23/sb; EPA GREEN: 08/23; E/CS is being covered under IS00445:05/24/sb; Upgraded from a "H" priority to an "H+" during the 2025 Pups & RUs process:10/24/sb; ISK has updated their support from Potential: E/CS Data Before Approval for Residue to Researchable, Residue & E/CS Data Needed so priority changed from a H+ to an A:10/17/24
|
| International Status: |
|
| Archive Location: |
|
| QA Archive: |
|